General Information of the Protein
Protein ID
PT04413
Protein Name
Vitamin K epoxide reductase complex subunit 1
Secondarily
Protein Name
Vitamin K1 2,3-epoxide reductase subunit 1
Gene Name
VKORC1
Secondarily
Gene Name
VKOR
MSTP134
MSTP576
UNQ308/PRO351
Sequence
MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSNSIFGCIFYTLQLLLGCLRTRWASVLMLLSSLVSLAGSVYLAWILFFVLYDFCIVCITTYAINVSLMWLSFRKVQEPQGKAKRH
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Oxidoreductase
Function
Involved in vitamin K metabolism. Catalytic subunit of the vitamin K epoxide reductase (VKOR) complex which reduces inactive vitamin K 2,3-epoxide to active vitamin K. Vitamin K is required for the gamma-carboxylation of various proteins, including clotting factors, and is required for normal blood coagulation, but also for normal bone development.
    Show/Hide
Uniprot ID
Primary ID:
Q9BQB6

Secondarily ID:
A6NIQ6
B2R4Z6
Q6UX90
Q7Z2R4
    Show/Hide
Ensembl ID
ENSG00000167397
HGNC ID
HGNC:23663
Subcellular Location
Endoplasmic reticulum membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Compound ID Compound Name Compound Formula
CP0944442
rac-4-(cycloocta-1,3,5,7-tetraenyl)-2-hydroxy-2-methyl-3,4-dihydropyrano[3,2-c]chromen-5(2H)-one
   Show/Hide
C21H18O4
 1
1
IC50 = 4.5 nM
   TI
   LI
   LO
   TS
CP0062501
2-hydroxy-3-(3-oxo-1-phenylbutyl)-4H-chromen-4-one
   Show/Hide
C19H16O4
 1
1
IC50 = 8.8 nM
   TI
   LI
   LO
   TS
CP0956189
(3'R,6R,8S)-6-(cycloocta-1,3,5,7-tetraenyl)-8-hydroxy-8-methyl-2-phenyl-7,8-dihydrospiro[[1,2,4]triazolo[1,2-a]pyridazine-5,3'-chroman]-1,3,4'(2H,6H)-trione
   Show/Hide
C29H25N3O5
 1
1
IC50 = 58.2 nM
   TI
   LI
   LO
   TS
CP0468886
3-(1-cyclooctyl-3-oxobutyl)-4-hydroxychromen-2-one
   Show/Hide
C21H26O4
 1
1
IC50 = 59 nM
   TI
   LI
   LO
   TS
CP0468887
3-(1-cyclohexyl-3-oxobutyl)-4-hydroxychromen-2-one
   Show/Hide
C19H22O4
 1
1
IC50 = 90.2 nM
   TI
   LI
   LO
   TS
CP0954385
rac-4-(1-(4-hydroxy-2-oxo-2H-chromen-3-yl)-3-oxobutyl)cycloocta-1,3,5,7-tetraenecarboxylic acid
   Show/Hide
C22H18O6
 1
1
IC50 = 1929 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Vitamin K epoxide reductase complex 1 (VKORC1) )
Target Type Successful Target
Disease 3 Target-related Diseases  3
1 Thrombosis [ICD-11: DB61-GB90]
2 Coagulation defect [ICD-11: 3B10.0]
3 Atrial fibrillation [ICD-11: BC81.3]
Approved Drug(s) 5 Approved Drugs  5
1 Acenocoumarol Approved
Thrombosis
2 Dicumarol Approved
Thrombosis
3 Phenindione Approved
Coagulation defect
4 Phenprocoumon Approved
Thrombosis
5 Warfarin Approved
Atrial fibrillation